Eli Lilly
Fastest-growing major pharma (+32% in 2024). Makers of Mounjaro, Zepbound, and affordable insulin. Industry leader in patient assistance.
Services Offered
Our Take
Lilly is the pharma success story of 2024 - 32% revenue growth driven by Mounjaro/Zepbound for weight loss. They also made waves with their $35 insulin cap, proving patient affordability can coexist with profits. Their Lilly Cares program is among the best in the industry. If cost is a barrier, always check Lilly Cares first.
Pros
- ✓$35 insulin program (industry-leading)
- ✓Best patient assistance in industry
- ✓Innovative weight loss drugs
- ✓+32% growth shows drug effectiveness
- ✓Transparent pricing initiatives
Cons
- ✗Mounjaro expensive without coverage ($1,000+/mo)
- ✗Supply issues for popular drugs
- ✗Some specialty drugs hard to access
Pricing Details
Lilly Cares provides free medications to qualifying patients. Pioneered $35/month insulin cap. Mounjaro assistance available.
Best For
- • Diabetes care
- • Weight loss (Mounjaro/Zepbound)
- • Affordable insulin
Coverage
- 📍 Global
Accreditations
- ✓FDA approved
Trust Indicators
Years in Business
148+
Last verified: December 21, 2024
⚠️ Important
Always verify pricing and details directly with the provider. Prices shown are estimates based on our research as of December 2024 and may have changed.
This information is for educational purposes only and does not constitute medical advice. Consult with qualified healthcare professionals before making medical decisions.
We may earn a commission if you use our links, but this does not affect our editorial opinions or the information presented.
Opens in new window • direct link